Related Experiment Video
Updated: Jun 23, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections
1Department of Biotechnology and Microbiology, Kannur University, Kerala, India.
Abstract:
Mycosis, caused by both filamentous fungi and pathogenic yeasts is a major concern nowadays especially in the immunocompromised patient population. The emergence of pathogenic fungi resistant to current therapies in the last few decades has intensified the search for new antifungals like cationic peptides, which are the key components of innate defense mechanism. The review provides an inventory of different peptides from a diverse array of organisms from bacteria to mammals with proven antifungal activity, their therapeutic options and also about those which are in various stages of preclinical development. Literature, on the total and semi-synthetic variants of the parent peptides that exhibit an improved antifungal activity is also reviewed.
Insights
Antifungal cationic peptides offer a promising alternative to combat drug-resistant fungi, especially in immunocompromised individuals. This review details peptides with proven antifungal activity and their therapeutic potential.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Mycosis poses a significant threat, particularly to immunocompromised patients.
- Increasing antifungal resistance necessitates novel therapeutic strategies.
- Cationic peptides are crucial components of the innate immune system with potent antimicrobial properties.
Purpose of the Study:
- To review existing and emerging cationic peptides with antifungal activity.
- To explore therapeutic applications and preclinical development of these peptides.
- To examine synthetic modifications enhancing antifungal efficacy.
Main Methods:
- Comprehensive literature search for antifungal peptides.
- Analysis of peptides from diverse biological sources (bacteria, fungi, mammals).
- Review of studies on semi-synthetic and fully synthetic peptide variants.
Main Results:
- Identification of numerous cationic peptides exhibiting broad-spectrum antifungal activity.
- Cataloging of peptides in various stages of therapeutic development.
- Evidence of improved antifungal potency in modified peptide structures.
Conclusions:
- Cationic peptides represent a vital class of novel antifungal agents.
- Further research and development hold significant promise for clinical applications.
- Synthetic modifications can optimize antifungal peptide efficacy and safety.
Related Concept Videos
Antifungal Agents
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Anthelminthic Agents

